Fig 2. Cohort 2: Flow diagram of immunized and control subjects.

Twenty-two subjects met all eligibility criteria and 12 were assigned to the true-immunization group, four were assigned to the mock-immunization group and the remaining six subjects were assigned as infectivity controls.